MOTS-C
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a 16-amino acid peptide encoded by mitochondrial DNA that acts as a retrograde signaling molecule from mitochondria to the nucleus
What is MOTS-C?
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a 16-amino acid peptide encoded by mitochondrial DNA that acts as a retrograde signaling molecule from mitochondria to the nucleus. Based on animal and lab studies, it appears to regulate cellular metabolism primarily through AMPK pathway activation.
Across SelfAssay's corpus, MOTS-C appears in 477 first-hand reports from 429 contributors, with overall community sentiment that reads as positive. Most of that discussion centers on Energy & Stimulation, Physical Performance & Recovery, and Weight Management & Appetite.
On SelfAssay, MOTS-C has a A (strong) Community Benefit read and a A (lower selected observed signal) observed AE-signal read. These are independent signals: how reliably people report the benefit they were after, and the identifiable-author share reporting selected serious or meaningful adverse events.
What people use MOTS-C for
What users report
From 477 first-hand reports across the community corpus.
What the community says about MOTS-C
Many people use MOTS-C to boost their cellular energy and aerobic endurance, often describing the effect as clean, steady energy that helps with midday fatigue and workout intensity. While some users find success with low doses like 1-2mg, others experiment with higher amounts or stack it with compounds like SS-31 and 5-Amino-1MQ to optimize their mitochondrial health. Results vary significantly, as a few users report feeling no difference or experiencing fatigue, highlighting that finding the right protocol often requires personal trial and error. Most users emphasize the importance of starting low and titrating up, noting that while some feel an immediate boost, others view it as a long-term investment in their metabolic and mitochondrial function.
Navigating MOTS-c protocols is clearly a game of trial and error, as everyone seems to be experimenting with different dosages and stacking strategies to find their personal sweet spot. While some users report success with high doses up to 10mg, others find that even 1.5mg to 3mg provides a noticeable endurance or energy boost. Many people prefer to cycle it alongside SS-31 for mitochondrial support, often timing their doses around workouts, though some outliers suggest taking it on rest days to avoid interfering with the body's natural exercise-induced release. It is a complex landscape where users are constantly adjusting frequencies, ranging from daily to once-weekly, and layering in other compounds like NAD+, Reta, or 5-amino, making it difficult to isolate the specific effects of any one peptide.
Individual experiences with MOTS-c vary wildly, ranging from reports of limitless energy and improved endurance to significant crashes and adverse side effects. While many users find success with low, titrated doses, often starting around 0.5mg to 1.5mg, others report feeling wired, experiencing insomnia, or facing severe fatigue when stacking it with other compounds. Some individuals notice profound improvements in recovery and daily stamina, whereas a few see negligible results despite consistent use. Ultimately, the consensus among those sharing their stories is that there is no universal protocol, and finding what works requires careful, personal experimentation while listening closely to your body's specific reactions.
Many users leverage MOTS-c as a metabolic signaling tool to boost energy, improve insulin sensitivity, and enhance fat oxidation, often stacking it alongside agents like Retatrutide or Tirzepatide to combat fatigue or stalled progress. While some report immediate energy spikes and improved gym intensity, others emphasize that results are cumulative, with many finding success in 1mg to 5mg doses administered daily or several times per week. A few users caution about potential side effects like hypoglycemia when stacking, suggesting that starting low and titrating up is the safest path to optimizing body composition.
Many users report that MOTS-C frequently triggers localized injection site reactions, ranging from minor itching and stinging to persistent lumps, welts, and redness that can last for several days. While some find that these effects are manageable through consistent site rotation, massaging the area, or letting the solution reach room temperature before pinning, others experience more intense histamine responses that may develop weeks into a cycle. A few individuals have successfully reduced these reactions by increasing the dilution with extra bacteriostatic water or taking antihistamines, though some outliers still face significant discomfort or even rare, severe allergic reactions requiring medical attention.
Themes are clustered from first-hand reports and summarized automatically. They describe what people report, not clinical fact.
Research and evidence for MOTS-C
Community Benefit figures come from qualified first-hand reports for the displayed purpose; the observed AE signal uses its separate deduplicated identifiable-author denominator. The 211 studies and 1 registered clinical trial linked below are research context only: they are not reconciled to the headline purpose or outcome and do not award either community grade. Displayed counts and grades are computed from their stated source and denominator, not generated; unavailable inputs are withheld rather than presented as a favorable result.
Is MOTS-C safe?
MOTS-C carries an observed AE-signal grade of A (lower selected observed signal), derived from 308 deduplicated identifiable authors reporting selected serious or meaningful adverse events rather than from a clinical risk model. The side effects people mention most often are fatigue, anaphylactic-shock, sleep-disturbance, and insomnia. This is not a complete safety profile, and MOTS-C can interact with other compounds and existing conditions. Review any plan with a qualified clinician before use.
Frequently asked questions
What is MOTS-C?
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a 16-amino acid peptide encoded by mitochondrial DNA that acts as a retrograde signaling molecule from mitochondria to the nucleus. Based on animal and lab studies, it appears to regulate cellular metabolism primarily through AMPK pathway activation.
What is MOTS-C used for?
In SelfAssay's community corpus, MOTS-C is most often used for Energy & Stimulation, Physical Performance & Recovery, Weight Management & Appetite, and Cardiometabolic & Heart Health. Each use case is graded separately, based on how consistently users report the result they were after.
What effects do people report from MOTS-C?
The most frequently reported effects are energy, enhanced exercise performance, weight loss, mitochondrial-function, and metabolic support. Overall community sentiment toward MOTS-C reads as positive, drawn from 477 first-hand reports.
What are the side effects of MOTS-C?
The side effects users mention most often are fatigue, anaphylactic-shock, sleep-disturbance, insomnia, and injection-site-lump. These are self-reported and not a complete safety profile; consult a clinician before use.
Is MOTS-C safe?
SelfAssay does not determine clinical safety. Its observed AE-signal grade is A (lower selected observed signal), based on deduplicated identifiable-author reports and not your individual health context.
How effective is MOTS-C?
MOTS-C holds a Community Benefit grade of A (strong) on SelfAssay, with its strongest grade for Energy & Stimulation. The grade reflects aggregated community reports; linked research is shown separately as context and results are not guaranteed.
How much research is there on MOTS-C?
SelfAssay's view of MOTS-C draws on 211 studies, 1 registered clinical trial, and 477 first-hand community reports, refreshed as new evidence is published.
Grade your own stack, free
See how MOTS-C reads alongside everything else you take across community Benefit, observed adverse-event signals, pair context, and linked Evidence context. Incomplete pair coverage stays provisional instead of being presented as an all-clear.
Grade my stackDecision support, not medical advice. Grades reflect community-reported experience and published literature, not a clinical assessment of your individual case. MOTS-C is provided for informational purposes; consult a qualified clinician before use.